Amedisys (AMED) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Amedisys Reports Second Quarter 2017 Financial Results
July 26, 2017 5:00 PM EDTBATON ROUGE, La., July 26, 2017 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2017.
Three Month Periods Ended June 30, 2017 and 2016
Net service revenue increased $18.1Â million to $378.8Â million compared to $360.7Â million in 2016.Net income attributable to Amedisys, Inc. of $4.5Â million compared to $10.7Â million in 2016.Net income attributable to Amedisys, Inc. per diluted share of $0.13 compared to $0.32 in 2016.Adjusted Quarterly Results*
Adjusted EBITDA of $36.1Â million compared to $29.8Â million in 2016.Adjusted net service revenue of $378.8Â million compared to... More